Free Trial

Trading of Polyrizon was halted at 10:35 AM EST due to "LULD pause".

NASDAQ:PLRZ

Polyrizon (PLRZ) Stock Price, News & Analysis

Polyrizon logo
$1.01 +0.76 (+298.58%)
As of 04:00 PM Eastern

About Polyrizon Stock (NASDAQ:PLRZ)

Key Stats

Today's Range
$0.51
$1.19
50-Day Range
$0.25
$0.88
52-Week Range
$0.25
$4.80
Volume
350.35 million shs
Average Volume
4.52 million shs
Market Capitalization
$4.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.

Receive PLRZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Polyrizon and its competitors with MarketBeat's FREE daily newsletter.

PLRZ Stock News Headlines

Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
Polyrizon Faces Nasdaq Compliance Challenge
See More Headlines

PLRZ Stock Analysis - Frequently Asked Questions

Polyrizon's stock was trading at $2.17 at the beginning of the year. Since then, PLRZ shares have decreased by 53.5% and is now trading at $1.01.
View the best growth stocks for 2025 here
.

Polyrizon (PLRZ) raised $4 million in an initial public offering on Tuesday, October 29th 2024. The company issued 958,903 shares at $4.38 per share.

Polyrizon's lock-up period expired on Monday, April 28th. Polyrizon had issued 958,903 shares in its public offering on October 29th. The total size of the offering was $4,199,995 based on an initial share price of $4.38. Since the end of Polyrizon's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

Shares of PLRZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PLRZ
Previous Symbol
NASDAQ:PLRZ
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$4.45 million
Optionable
N/A
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:PLRZ) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners